Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $158.35 +0.35%
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: +30.8%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Lowered to $92 at Mizuho
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- Neurocrine Bio. (NBIX) PT Raised to $253 at Citi
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
